Development of [64Cu]-DOTA-anti-CD20 for targeted therapy
暂无分享,去创建一个
P. Rowshanfarzad | A. Jalilian | M. Kamalidehghan | L. Mirsadeghi | Y. Yari-kamrani | M. Sabet | M. Kamali-dehghan
暂无分享,去创建一个
P. Rowshanfarzad | A. Jalilian | M. Kamalidehghan | L. Mirsadeghi | Y. Yari-kamrani | M. Sabet | M. Kamali-dehghan